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Impaired Wound Repair in Adult Endoglin
Heterozygous Mice Associated with Lower NO
Bioavailability
Eduardo Pe´rez-Go´mez1,5, Mirjana Jerkic2,3, Marta Prieto2, Gaelle del Castillo1, Ester Martı´n-Villar1,
Michelle Letarte3, Carmelo Bernabeu4, Fernando Pe´rez-Barriocanal2, Miguel Quintanilla1 and
Jose´ M. Lo´pez-Novoa2
Endoglin (Eng) is a transmembrane glycoprotein that is mainly expressed in endothelial cells, but it is also present
in the epidermis and skin appendages. To address the role of Eng in cutaneous wound healing, we compared the
kinetics of reepithelialization in Eng heterozygous null (Engþ / ) mice and their normal littermates (Engþ /þ )
following skin wounds. The wound area was significantly larger in Engþ / than in Engþ /þ mice from 2 to 8 days
after injury; overall wound closure was delayed by 1 to 2 days. In Engþ / mice, keratinocytes at the wound edges
exhibited impaired proliferation but were more migratory, as shown by their elongated morphology and
increased keratin 17 expression. Inhibition of nitric oxide (NO) synthesis delayed healing in Engþ /þ but not in
Engþ / mice. Administration of the NO donor LA-803 accelerated wound closure in Engþ / mice, with no effect
on normal littermates. The acute stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA) enhanced Eng
expression in mouse epidermal keratinocytes in vivo and in vitro associated with hyperproliferation. Similarly, the
skin of Engþ / mice failed to mount a hyperplastic response to acute stimulation with TPA. These results
demonstrate an important involvement of Eng in wound healing that is associated with NO bioavailability.
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INTRODUCTION
Physiological wound healing is a highly organized process
requiring tight temporal and spatial coordination of various
events and signaling networks (Martin, 1997; Grose and
Werner, 2004; Gurtner et al., 2008). Cutaneous wound
healing begins immediately after a skin injury in an attempt
to provide a protective barrier against further external stimuli
or infections. Proper skin wound repair requires the
coordinated activation of several cell and tissue responses,
including reepithelialization, connective tissue contraction,
and angiogenesis, the latter process leading to the formation of
a dense network of blood vessels in the wound granulation
tissue. A robust inflammatory response commencing soon
after tissue damage, followed by tissue remodeling, is also an
important step in tissue repair (Martin, 1997). The wound
healing process is interactive and dynamic, involving the
extracellular matrix, multiple soluble mediators, blood cells,
keratinocytes, and parenchymal cells (Coulombe, 2003).
Delayed skin wound healing is a serious complication in
diabetes and is caused primarily by microangiopathy and
impaired cutaneous blood flow, hypoxia, accelerated
inflammation, edema, and endothelial dysfunction (Reiber
et al., 1999; Martin et al., 2003). Moreover, expression of
vascular endothelial growth factor-A is markedly reduced in
wounds of diabetic patients (Frank et al., 1995; Kampfer et al.,
2001).
The genetic control of wound healing involves multiple
families of growth factors, of which transforming growth
factor-b (TGF-b) is a classic example (Singer and Clark,
1999). TGF-b expression occurs throughout wound healing
and regulates many processes involved in tissue repair
(Valluru et al., 2011a). Endoglin (CD105) is a 180-kDa
homodimeric transmembrane glycoprotein that modulates
cellular responses to ligands of the TGF-b superfamily
(Gougos and Letarte, 1990; Barbara et al., 1999; Li et al.,
2000; Lo´pez-Novoa and Bernabe´u, 2010). Endoglin (Eng) is
upregulated in tissues undergoing angiogenesis (Fonsatti et al.,
2003; Jerkic et al., 2006a; Lo´pez-Novoa and Bernabe´u, 2010),
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and inhibition of its expression in endothelial cells impairs this
process (Li et al., 2000). Endoglin-null mice die at mid-gesta-
tion from defective angiogenesis and severe cardiovascular
abnormalities, whereas Endoglin heterozygous (Engþ / ) mice
have a normal lifespan (Bourdeau et al., 1999; Li et al., 1999;
Arthur et al., 2000). Eng has been shown to regulate vascular
function through modulation of endothelial nitric oxide (NO)
synthase (NOS) expression and activity, with Eng haplo-
insufficiency being associated with reduced NO production
and increased endothelial NOS–derived superoxide produc-
tion (Jerkic et al., 2004; Toporsian et al., 2005; Jerkic et al.,
2006a). Reduced NO production has now been demonstrated
in lungs, heart, and liver of Engþ / mice (Jerkic et al 2012).
Eng has also been shown to have a major role in the regulation
of angiogenesis (Jerkic et al., 2006b; Lebrin and Mummery,
2008).
Eng is expressed in keratinocytes of the interfollicular
epidermis and hair bulbs where it acts to attenuate TGF-b
signaling (Quintanilla et al., 2003; Pe´rez-Go´mez et al., 2007).
Eng expression increases after dermal wound in asso-
ciation with inflammation (Torsney et al., 2002). In addition,
Eng is overexpressed in some skin diseases such as
scleroderma or psoriasis (Rulo et al., 1995; Maring et al.,
2012). The purpose of this study was to assess the role
of Eng in epidermal reepithelialization by studying the effect
of Eng insufficiency on cutaneous healing after an excisional
wound.
RESULTS
Temporal and spatial expression of Eng during repair
We first analyzed Eng expression during wound healing in
normal mice (Supplementary Figure S1 online). Eng expression
was low in control skin (day 0), but gradually increased after
wounding, reaching maximal values 4 days after the injury
and decreasing by 8 days (Supplementary Figure S1a online).
The localization of Eng expression in the wounded area was
also determined by immunohistochemical analysis. Basal-like
keratinocytes at the wound edges and blood vessels of the
subepithelial area were the main cellular sources of Eng
protein (Supplementary Figure S1b online). Note the faint
expression of Eng in keratinocytes in the interfollicular,
nonwounded skin (arrowheads) and the high expression of
Eng in the keratinocytes of the reepithelializing skin (black
arrows, insert).
Delayed wound closure in Eng-deficient mice
We introduced full-thickness wounds into the dorsal skin of
Engþ /þ and Engþ / mice and analyzed wound closure 2–14
days after the injury, as indicated in the Materials and
Methods. Engþ / mice exhibited delayed wound closure
compared with Engþ /þ mice, showing a significantly larger
wound from days 2 to 8 after injury (Figure 1a). At 4 days after
wounding, B60% wound closure was observed in Engþ /þ
mice as compared with 40% in Engþ / mice. In Engþ /þ
mice, wound closure was complete by day 12, whereas in
Engþ / animals this occurred 1 or 2 days later. The rate of
healing, expressed as the half closing time, was 3.2±0.2 days
in Engþ /þ and 4.2±0.2 days in Engþ / mice (Figure 1c).
Oral administration of the NOS inhibitor Nw-Nitro-L-argi-
nine methyl ester (L-NAME) significantly delayed wound
healing in Engþ /þ mice, but the effect was minimal in
Engþ / mice (Figure 1a and c). In contrast, administration
of the NO donor LA-803 accelerated the rate of healing
in Engþ / mice, with almost no effect in Engþ /þ mice
(Figure 1b and c). These results suggest that reduced NO
levels, previously reported in several organs of Engþ / mice
(Jerkic et al., 2012), have a crucial role in the delayed wound
healing observed in Engþ / mice.
Histological examination of the wounds revealed that
4 days after the injury the hyperproliferative epithelium at
the wound edges was thinner in Engþ / mice as compared
with Engþ /þ mice (Figure 2a and b). However, keratinocytes
forming the new epithelium in Engþ / wounds exhibited
a more elongated morphology than those of normal mice
(see below). The difference in thickness of the regenerated
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Figure 1. Wound healing is delayed in endoglin (Eng)-deficient mice.
(a) Wound closure kinetics in normal and mutant mice before and after
oral administration of the inhibitor of nitric oxide (NO) synthesis
Nw-Nitro-L-arginine methyl ester (L-NAME). (b) Wound closure kinetics in
normal and mutant mice before and after oral administration of the NO donor
LA-803. Data are shown as mean±SEM (n¼ 11 animals per group). *Po0.01
versus Engþ /þ ; &Po0.01 versus Engþ / . (c) The half closing time (HCT) of
the wounds for the different treatments was determined. #Po0.01 versus
Engþ /þ without treatment; &Po0.01 versus Engþ / without treatment.
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epidermis between Engþ /þ and Engþ / mice was also
evident at 12 days after the injury when wounds were
completely re-epithelialized (Figure 2c and d). Thus, the
regenerated epithelium in Engþ / mice was formed by only
1–2 layers (Figure 2d), which was in clear contrast with the
3–5 layers that were formed in the new epidermis of Engþ /þ
mice (Figure 2c). To substantiate this difference further,
epidermal thickness was measured in five sections of each
genotype, each section corresponding to a mouse (four fields
per section). Epidermal thickness was 153±11mm in Engþ /þ
mice and 72±5mm in Engþ / mice (Po0.01).
Disturbed epidermal proliferation in Eng-deficient mice
To determine the proportion of proliferating keratinocytes in
the regenerating epithelium of normal and mutant mice,
we performed Ki67 staining in the epidermis adjacent to the
wounds in unwounded areas, and no evident differences in
terms of the number of Ki67-positive keratinocytes in the basal
layer were observed between Engþ /þ and Engþ / (Figure 3a
and b). Nevertheless, in wounded areas, a clear reduction
in the number of Ki67-positive keratinocytes was observed in
mutant mice as compared with normal mice (as shown in
Figure 3c and d for wounds 4 days after the injury). Even at 12
days after wounding, proliferation was still observed in the
basal layer of the regenerated epidermis of Engþ /þ mice
(Figure 3e), whereas only faint Ki67 staining was seen in the
new epithelium of Engþ / mice (Figure 3f). These results,
together with the histological analysis presented in Figure 2,
suggest that the activation of keratinocyte proliferation after
cutaneous injury is defective in Eng-deficient animals.
Keratin 17 (K17) is expressed by activated suprabasal
keratinocytes migrating onto the wound bed (Patel et al.,
2006). Immunofluorescence staining of K17 in wounds at
6 days after the injury revealed that both the number of
K17-positive cells and the intensity of staining were increased
in Engþ / mice (Supplementary Figure S2c and d online) as
compared with Engþ /þ mice (Supplementary Figure 2a and b
online), suggesting that the epidermis of Engþ / mice
adjacent to the wound, although unable to accumulate
proliferating cells, contained a higher number of migratory
keratinocytes compared with the epidermis of normal mice.
To further analyze the relationship between epidermal
proliferation and Eng, the skin of normal and mutant mice
was subjected to an acute proliferative stimulus with the tumor
promoter 12-O-tetradecanoylphorbol-13-acetate (TPA). Skin
sections were taken 24 and 48 hours after the application of
either TPA or vehicle (acetone), and Eng expression was
analyzed by real-time quantitative reverse transcription–PCR
and western blotting. TPA significantly increased Eng levels
in both Engþ /þ and Engþ / mice, although the increase
was lower in Eng-deficient animals (Figure 4a and b). Eng
expression in the epidermis of mice treated with vehicle alone
was barely detected. However, in TPA-stimulated mice, the
expression of Eng in the interfollicular epidermis was highly
increased, was restricted to the basal-like layer, and was
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Figure 2. Reepithelialization is defective in endoglin (Eng)-deficient mice.
Representative histological appearances of wounds in (a, c) wild-type and
(b, d) Engþ / mice (a, b) 4 days and (c, d) 12 days after wounding. Black
arrows in a and b indicate the estimated limit between unwounded and
reepithelialized skin, whereas red arrow marks the tip of the regenerating
tongue. G, granulation tissue; P, panniculus carnosus; S, scab. Scale
bar¼ 210mm.
Figure 3. Reduced keratinocyte proliferation in the wounded epidermis of
Endoglin (Eng)-deficient mice. Representative Ki67 immunostaining (brown-
stained nuclei in the epidermis) in (a, b) unwounded and (c, d) wounded skin at
4 days and (e, f) 12 days after the injury of (a, c, e) normal and (b, d, f) Engþ /
mice. In c and d, the tip of the regeneration tongue is marked with a red arrow.
In e and f, approximate limits of regenerating skin in the wound are marked
with red arrows. Scale bar¼210mm.
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associated with hyperproliferation as found by colocalization
of Eng and Ki67 immunofluorescence staining (Figure 4c).
TPA was also able to stimulate Eng expression in cul-
tured premalignant keratinocytes (Supplementary Figure S3
online). It is well known that marked hyperplasia is an early
event seen after topical application of TPA (Argyris, 1982).
The comparison of epidermal thickness in vehicle-treated and
TPA-treated animals revealed that the hyperplastic response
was strongly inhibited in Engþ / as compared with Engþ /þ
mice (Figure 5a and b), as expected because of the restrained
proliferative capacity of keratinocytes in Eng-deficient animals
(Figure 5c).
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Figure 4. TPA stimulates endoglin (Eng) expression in the epidermis associated with hyperproliferation. Normal and mutant mice were subjected to a single
topical application of 12-O-tetradecanoylphorbol-13-acetate (TPA) or vehicle (acetone), and the expression of Eng was determined 48 hours after the treatment.
(a) Transcriptional expression of Eng determined by real-time quantitative PCR. Normalized Eng transcripts were measured relative to glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). Data are expressed as mean±SEM from triplicate determinations.**Po0.01 versus Engþ /þ . (b) Western blot analysis of Eng
protein expression. b-Actin was used as a control for protein loading. (c) Representative immunofluorescence analysis of Eng and Ki67 expression in the
interfollicular epidermis of wild-type mice treated or not treated with TPA. Nuclei were stained with 4’,6-diamidino-2-phenylindole (DAPI). Note the strong
colocalization of Eng and Ki67 in basal-like keratinocytes. Scale bar¼ 50mm.
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DISCUSSION
Eng has crucial functions in angiogenesis and inflammation
(Bernabeu et al., 2007; ten Dijke et al., 2008; Lo´pez-Novoa
and Bernabe´u, 2010), two processes intimately linked to
wound healing (Valluru et al., 2011a). In this work, we
show that skin wound healing is delayed in Eng-deficient
mice, in particular at 2–8 days after the injury. In normal mice,
Eng expression is enhanced promptly in keratinocytes and
blood vessels of wounded skin (Supplementary Figure S1
online). A rapid increase in Eng expression was previously
reported in proliferating endothelial cells and infiltrating
inflammatory cells in skin punch biopsies from human
volunteers (Torsney et al., 2002). Elevated Eng expression
was also observed in blood vessels in surgical wounds at
3 days after surgery, suggesting a role for Eng in human
cutaneous repair and scar formation (Valluru et al., 2011b).
We show in this report that the lower rate of healing observed
in Eng heterozygous mice is associated with impaired kerati-
nocyte proliferation at the wound edges, and decreased NO
bioavailability.
We have previously reported the expression of Eng in
epidermal keratinocytes from the proliferative basal layer, hair
bulbs, and sebaceous glands (Quintanilla et al., 2003).
Carcinogenesis experiments carried out in Engþ / mice
suggested a crucial function of Eng in epidermal homeostasis
by attenuating TGF-b signaling in order to allow keratinocyte
proliferation (Quintanilla et al., 2003; Pe´rez-Go´mez et al.,
2005). Therefore, the burst of Eng expression in keratinocytes
immediately after wounding appears to be related to the wave
of epidermal hyperproliferation occurring in the epidermis
adjacent to the wound to replenish the wounded area
with new cells. In Eng-deficient mice, the lack of a
hyperproliferative epithelium at the wound edges is evident,
as shown by histological and Ki67 immunostaining analyses
(Figures 2 and 3). A close relationship between Eng and
epidermal proliferation was confirmed by analyzing the skin
of Engþ / and Engþ /þ mice after a single topical application
of TPA. As occurred in wounded skin, TPA stimulated the
expression of Eng in the basal layer of normal epidermis, and
this enhancement was associated with hyperproliferation, as
seen by Ki67 staining (Figure 3). Both Eng expression and the
strong epidermal hyperplasia induced by TPA in normal mice
were attenuated in Eng heterozygous mice (Figure 3). Inter-
estingly, the epidermis of mutant mice contained a larger
subpopulation of keratinocytes migrating into the wounded
area than that of wild-type mice, as suggested by its elongated
morphology and K17 staining (Figure 3). Although we cannot
rule out the possibility of the sectioning angle influencing the
shape of the cells, the repeated appearance of more elongated
cells in Engþ / mice suggests this migratory phenotype.
These results are compatible with in vitro studies showing
that the knockdown of Eng in transformed keratinocytes
constitutively activates TGF-b signaling, simultaneously lead-
ing to growth arrest and increased migration (Pe´rez-Go´mez
et al., 2007). In fact, TGF-b1, which is released in large
amounts from platelets immediately after wounding
(Assoian et al., 1983), promotes keratinocyte migration
and reepithelialization during wound healing (reviewed
in Werner and Grose, 2003). In addition, TGF-b3 has been
found to regulate epidermal cell migration (Bandyopadhyay
et al., 2006).
Several reports point to an important role of NO in wound
healing (reviewed in Schwentker et al., 2002; Witte and
Barbul, 2002). Thus, clinical studies have revealed that oral
administration of the NO donor L-arginine has a beneficial
effect on wound healing (Barbul et al., 1990; Kirk et al., 1993).
The constitutive, endothelial, neuronal, and inducible NO
synthases are expressed during wound healing, and several
reports have shown that either reduced activity or expression
of NOS leading to decreased NO production has a detrimental
effect on wound healing (Schaffer et al., 1996; Yamasaki et al.,
1998; Lee et al., 1999). We have reported decreased NO
production in Engþ / mice caused by reduced endothelial
NOS expression (Jerkic et al., 2004) or uncoupling of the
enzyme with the chaperone Hsp90, leading to superoxide
production rather than NO production (Toporsian et al., 2005;
Jerkic et al 2012). In this work, we show that delayed wound
closure in Eng-deficient mice is also associated with
diminished NO bioavailability, as increasing NO production
in Engþ / mice by oral administration of a NO donor
accelerated the rate of healing, whereas inhibition of NO
synthesis in normal mice significantly delayed wound healing
(Figure 1). Deficient NO synthesis in the wounds of Engþ /
mice may result in a marked loss of the keratinocyte pro-
liferative capacity (Frank et al., 1999; Stallmeyer et al., 1999),
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Figure 5. Mutant mice exhibit reduced hyperplasia in response to
12-O-tetradecanoylphorbol-13-acetate (TPA). (a) Representative histological
appearances of the skin of a normal and mutant mouse 24 hours after a single
topical application of TPA (or vehicle). Sections were counterstained with
hematoxylin and eosin (H&E). Note the clear hyperplasia induced in normal
skin. Scale bar¼ 50mm. (b, c) Quantification of epidermal thickness and the
proportion of Ki67-positive keratinocytes 24 hours after TPA (or vehicle)
stimulation. Data are shown as mean±SEM (n¼ 6 animals per group;
5 different fields in each animal). AU, arbitrary units; Eng, endoglin.
**Po0.01 versus TPA-treated Engþ /þ mice.
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as well as impaired keratinocyte production of vascular
endothelial growth factor and chemotactic cytokines (Frank
et al., 1999, 2000; Wetzler et al., 2000). In fact, Stallmeyer
et al. (1999) have described that the amorphous mass of
keratinocytes that spread over the wounded tissue present in
untreated animals was reduced to a flat cell tongue covering
the wound. They also reported in mice treated with L-N6-
(1-iminoethyl)-lysine (L-NIL), a selective inhibitor of inducible
NOS enzymatic activity, a situation similar to that observed
by us in Eng-deficient mice. In addition, angiogenesis may
also be affected, as endothelial cells isolated from Engþ /
mice show reduced proliferation, migration, and capillary
tube formation associated with decreased endothelial NOS
activity and vascular endothelial growth factor secretion
(Jerkic et al., 2006a). Eng regulates angiogenesis by
modulating TGF-b signaling through the type I activin-like
kinase receptors ALK1 and ALK5 (reviewed in Lebrin and
Mummery, 2008). Whereas there are conflicting results about
the precise roles of these receptors in angiogenesis, it is clear
that Engþ / mice exhibit a reduced angiogenic response
in vivo (Du¨wel et al., 2007; Jerkic et al., 2006b), suggesting
that Eng haploinsufficiency during wound healing leads to the
inhibition of the angiogenic switch likely by disturbed TGF-b
signaling.
A schematic model depicting the effects of Eng haplo-
insufficiency on TGF-b signaling and NO production is
presented in Figure 6. A normal level of Eng expression during
wound healing favors angiogenesis and keratinocyte prolifera-
tion by modulating NO synthesis and TGF-b signaling in the
endothelial and epidermal compartments (Figure 6a). Eng
haploinsufficiency in mutant mice leads to defective angio-
genesis in the endothelial compartment owing to disturbed
TGF-b signaling, whereas in the epidermis, reduced Eng
expression allows increased TGF-b signaling that, in turn,
results in decreased proliferation and increased keratinocyte
migration (Figure 6b). Furthermore, alterations in myofibro-
blast function have recently been reported after wounding in
Engþ / mice (Pericacho et al., 2013). Thus, Eng seems to
control many of the integrated processes involved in proper
healing, including adequate function of endothelial cells,
myofibroblasts, and keratinocytes.
It should be noted that, in addition to being involved in
wound healing, Eng is overexpressed in several skin patho-
logies, including scleroderma (Leask et al., 2002; Maring
et al., 2012; Morris et al., 2011), psoriasis (Rulo et al., 1995;
van de Kerkhof et al., 1998), and irradiated skin (Wang et al.,
1995). All these data support the relevance of Eng in skin
function and disease.
MATERIALS AND METHODS
Animals
Generation and genotyping of Engþ / mice on a C57Bl/6 back-
ground has been previously described (Bourdeau et al., 1999;
Rodrı´guez-Pen˜a et al., 2002). Mice were kept in ventilated rooms.
Lighting and temperature were controlled by a timer that permitted
light between 0800 and 2000 hours and a temperature of 20±1 1C.
Mice were fed with standard mouse chow (Panlab, Madrid, Spain)
and water ad libitum. All studies were conducted in parallel in Engþ /
and Engþ /þ littermate female mice aged 4–6 months (20–25 g).
All animal procedures were in accordance with the guidelines for
animal use published by Conseil de l´Europe (No. L358/1–358/6,
1986), Spanish Government (BOE No. 67, pp. 8509–8512, 1988, and
BOE No. 256, pp. 31349–31362, 1990), and were approved by the
University of Salamanca Animal Care and Use Committee.
Wounding procedure and wound closure analysis
Mice were anesthetized with isoflurane (starting with 2–3% and main-
tained with 1%; Forane, Abbott, Abbott Park, IL). Two full-thickness
wounds (5 mm in diameter, 5 mm apart) were made on the back of
the mice by excising the skin and the underlying panniculus carnosus.
Every 2 days after wounding, mice were anesthetized with isoflurane,
and wound borders were drawn on a transparent film. Wound areas
(in mm2) were calculated from wound perimeter tracings by photo-
graphic analysis using the SCION IMAGE software (Scion, Houston, TX).
The original area of each wound (day 0) was given a value of 100, and
the wounded area on subsequent days was expressed as a percentage
of the original area. To assess the rate of healing, we calculated the
time at which wounds were closed by 50% (half closing time).
Endothelial cell Keratinocyte
Endoglin
NO
Proliferation
KeratinocyteEndothelial cell
Endoglin high expression
Endoglin low expression
Migration
Migration
Endoglin
NO
Proliferation
Endoglin
NO
Angiogenesis
TGF-β signaling TGF-β signaling
TGF-β signaling
Endoglin
NO TGF-β signaling
Angiogenesis
Figure 6. Schematic model representing the effects of endoglin (Eng)
haploinsufficiency on the endothelial and epidermal cell compartments
during wound healing. (a) Normal Eng. (b) Low Eng. In endothelial cells, Eng
deficiency results in reduced nitric oxide (NO) synthesis and disturbed
transforming growth factor-b (TGF-b) signaling that impairs the angiogenic
response. In the epidermal compartment, reduction of NO synthesis and
constitutive activation of TGF-b signaling as a consequence of Eng
haploinsufficiency result in the inhibition of keratinocyte proliferation and
stimulation of migration.
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Skin samples were obtained at different days after injury, and the
mouse was then killed. At each time point, an area that included the
scab and the complete epithelial margin was excised from each
individual wound. As a control, a similar area of skin was taken from
the back of unwounded mice.
Local NO donor administration and NO synthesis blockade
To inhibit NO synthesis in vivo, L-NAME (Sigma, Madrid, Spain) was
applied at a dose of 10 mg kg 1 per day in the drinking water of
groups of 11 Engþ / and Engþ /þ mice until full wound closure.
The same procedure was used to dispense the nitrosothiol NO donor
LA-803 (30 mg kg 1 per day), kindly provided by Lacer, Barcelona,
Spain (Garcı´a-Criado et al., 2009).
Acute TPA treatment
A single dose of TPA (12.5mg) or the corresponding vehicle (200ml of
acetone) was applied onto the shaved dorsal skin of groups of Engþ /þ
and Engþ / mice. Animals were killed at 24 or 48 hours of treatment,
and skin was collected. Samples were divided into portions that were
either fixed in formaldehyde (for immunofluorescence, immuno-
histochemistry, and hematoxylin and eosin staining) or snap-frozen
(for protein and RNA extraction). Frozen samples were stored at
 80 1C until analysis. In addition, MCA3D premalignant keratino-
cytes (Pe´rez-Go´mez et al., 2007) were treated with TPA (100 ng ml 1
in DMSO) for 24 and 48 hours, or with vehicle alone for 48 hours,
and Eng expression was determined by real-time quantitative reverse
transcription–PCR and western blotting, as described later.
Western blot analysis
Skin samples were homogenized in lysis buffer (1% Triton X-100,
20 mM Tris/HCl, pH 8.0, 137 mM NaCl, 10% glycerol, 5 mM EDTA,
1 mM phenylmethylsulfonyl fluoride, 1mg ml 1 aprotinin, and
1mg ml 1 leupeptin) and lysates were cleared by centrifugation at
14,000 g. Aliquots of 50mg of total lysate protein were separated by
SDS-gel electrophoresis and electrotransferred to PVDF membranes.
For the detection of Eng, a-tubulin, and a-actin, the mAbs MJ7/18
(Ge and Butcher, 1994), sc-8035 (Santa Cruz Biotechnology, Dallas,
TX), and AC-15 (Sigma-Aldrich, Madrid, Spain), respectively, were
used, followed by appropriate secondary antibodies coupled to
horseradish peroxidase. The peroxidase activity was developed
using an enhanced chemiluminescence kit (Amersham Biosciences,
Barcelona, Spain).
Quantitative reverse transcription–PCR
Quantitative reverse transcription–PCR analysis was carried out as
previously described (Pe´rez-Go´mez et al., 2007). The gene encoding
mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was
used as an internal control of the RNA quality and amplification.
Primers for mouse Eng were 50-ACAAGGGGTGAGGTGACGTT-30
and 50-GAAACGAGGACCAGGAACAC-30; and for GAPDH were
50-TAATGAGCTGGTCATCCGTG-30 and 50-CAGGCTTCCCTGAGT
TCATC-30. The annealing temperatures were 56 and 55 1C,
respectively.
Histology, immunohistochemistry, and immunofluorescence
analyses
For histological analysis, dissected wounds were fixed in 4% buffered
formaldehyde for 24 hours, followed by dehydration through a graded
ethanol series, and they were then embedded in paraffin. Sections of
3mm thickness were cut, mounted on glass slides, and processed.
One set of slides were rinsed with water, counterstained with
hematoxylin and eosin, washed in water, and dehydrated and
mounted with a coverslip using Tissue-Tek (Miles, Fergus Falls,
MN). Other sets of slides were subsequently incubated for 1 hour at
room temperature using rabbit polyclonal antibodies recognizing
mouse Eng (sc20632, dilution 1:10; Santa Cruz Biotechnology) or
Ki67 (MAD-020310Q, dilution 1:25; Master Diagno´stico S.L.,
Granada, Spain). The slides were stained with the avidin–biotin
peroxidase complex system from Santa Cruz Biotechnology using 3-
amino-9-ethylcarbazole as a chromogenic substrate and mounted
with a coverslip using Tissue-Tek (Miles). For inmunohistochemical
K17 detection, epitope retrieval was performed in a steamer for
3 minutes in 10 mM sodium citrate buffer (pH 6.0), followed by
staining with a-K17 Ab-1 (Labvision, Kalamazoo, MI). Immunodetec-
tion was performed using the labeled streptavidin-biotin method
(DAKO, Barcelona, Spain) with 3,30-diaminobenzidine as the
chromogen.
Quantification of epidermal hyperplasia in skin treated with TPA
or vehicle was performed in hematoxylin and eosin–stained sections
of Engþ /þ (n¼ 6) and Engþ / (n¼ 6) littermates in five different
fields each.
For immunofluorescence analysis in skin treated with TPA, paraffin-
embedded sections were fixed in 3.7% formaldehyde and subjected
to heat-induced antigen retrieval for 9 minutes in Tris-EDTA buffer
(10 mM Tris Base, 1 mM EDTA, pH 9.0) before exposure to primary
antibodies. The mAb MJ7/18 recognizing mouse Eng (Ge and
Butcher, 1994) and anti-Ki67 from Neomarkers/Lab Vision,
(Fremont, CA) were used. Secondary anti-rat and anti-rabbit Alexa
Fluor 594 and Alexa Fluor 488 antibodies were from Invitrogen
(Carlsbad, CA). Cell nuclei were stained with 4’,6-diamidino-2-
phenylindole from Invitrogen. Fluorescence confocal images were
acquired using the Leica TCS-SP2 software (Wetzlar, Germany).
Quantification of Ki67-positive nuclei was performed in five
different fields, with 3 mice for each condition.
Statistical analysis
Between-group comparisons were performed by analysis of variance
and corrected for repeated measures when appropriate. If analysis of
variance revealed overall significant differences, individual means
were evaluated post hoc using the Bonferroni procedure. Results are
expressed as the mean±SEM.
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